JAK2 GGCC (46/1) Haplotype in Unprovoked Venous Thrombotic Events

被引：0
|
作者：
Al-Ammari, Maged [1 ]
Zada, Abdul Ali Peer [2 ,3 ]
Motabi, Ibraheem H. [1 ]
Albtoosh, Belal M. [4 ]
Altaf, Syed Y. [1 ]
Tailor, Imran K. [1 ]
Alnoamani, Mohammed S. [1 ]
Zaidi, Syed Ziauddin A. [1 ]
Alfayez, Mansour [1 ]
Alshehry, Nawal F. [1 ]
Marei, Mohammed A. [1 ]
机构：
[1] King Fahad Med City, Ctr Comprehens Canc, Dept Adult Hematol, BMT, Riyadh, Saudi Arabia
[2] King Fahad Med City, Mol Pathol Sect, Pathol & Clin Lab Adm, Riyadh, Saudi Arabia
[3] King Fahad Med City, Riyadh, Saudi Arabia
[4] King Fahad Med City, Dept Nursing, Riyadh, Saudi Arabia
来源：
BLOOD | 2021年 / 138卷
关键词：
D O I：
10.1182/blood-2021-149560
中图分类号：
R5 [内科学];
学科分类号：
1002 ; 100201 ;
摘要：
4258
引用
收藏
页数：3
相关论文
共 50 条
  • [21] The Contribution of JAK2 46/1 Haplotype in the Predisposition to Myeloproliferative Neoplasms
    Paes, Jhemerson
    Silva, George A., V
    Tarrago, Andrea M.
    de Souza Mourao, Lucivana P.
    INTERNATIONAL JOURNAL OF MOLECULAR SCIENCES, 2022, 23 (20)
  • [22] THE ROLE OF THE JAK2 GGCC HAPLOTYPE, TET2, AND CBL IN FAMILIAL MYELOPROLIFERATIVE NEOPLAMS
    Olcaydu, D.
    Rumi, E.
    Harutyunyan, A.
    Passamonti, F.
    Pietra, D.
    Berg, T.
    Jaeger, R.
    Klampfl, T.
    Kralovics, R.
    Cazzola, M.
    HAEMATOLOGICA-THE HEMATOLOGY JOURNAL, 2010, 95 : 163 - 163
  • [23] JAK2 HAPLOTYPE 46/1 (GGCC) HAS NO EFFECT ON THE PRIMARY RISK OF JAK2 V617F MUTATION, BUT IT STRONGLY POTENTIATES THE PROGRESSION OF GROWN ALLELE BURDEN IN MYELOPROLIFERATIVE NEOPLASMS
    Stolyar, M.
    Klimova, O.
    Ivanov, M.
    Gorbenko, A.
    Titov, S.
    Olkhovskiy, I.
    HAEMATOLOGICA, 2017, 102 : 539 - 539
  • [24] The role of the JAK2 GGCC haplotype and the TET2 gene in familial myeloproliferative neoplasms
    Olcaydu, Damla
    Rumi, Elisa
    Harutyunyan, Ashot
    Passamonti, Francesco
    Pietra, Daniela
    Pascutto, Cristiana
    Berg, Tiina
    Jaeger, Roland
    Hammond, Emma
    Cazzola, Mario
    Kralovics, Robert
    HAEMATOLOGICA-THE HEMATOLOGY JOURNAL, 2011, 96 (03): : 367 - 374
  • [25] THE JAK2 46/1 (GGCC) HAPLOTYPE IS ASSOCIATED WITH PRIMARY MYELOFIBROSIS INDEPENDENTLY OF V617F MUTATIONAL STATUS, DISEASE CHARACTERISTICS OR PROGNOSIS
    Vannucchi, M.
    Guglielmelli, P.
    Biamonte, F.
    Spolverini, A.
    Pancrazzi, A.
    Pieri, L.
    Isgro, A.
    Antonioli, E.
    Bartalucci, N.
    Bosi, A.
    Barosi, G.
    HAEMATOLOGICA-THE HEMATOLOGY JOURNAL, 2010, 95 : 471 - 471
  • [26] EVALUATION OF THE ASSOCIATION BETWEEN JAK2 46/1 HAPLOTYPE AND MYELOPROLIFERATIVE NEOPLASMS
    Ha, J. S.
    Park, S.
    Kim, K.
    Lee, J.
    Lee, W.
    Ryoo, N.
    Jeon, D.
    Kim, J.
    Do, Y.
    Kwon, K.
    Jung, H.
    Chung, I.
    HAEMATOLOGICA, 2014, 99 : 125 - 126
  • [27] THE ASSOCIATION BETWEEN JAK2 46/1 HAPLOTYPE AND SUSCEPTIBILITY TO MYELOPROLIFERATIVE NEOPLASMS
    Ouyang, J.
    Feng, X.
    Zhou, M.
    HAEMATOLOGICA, 2013, 98 : 625 - 625
  • [28] The JAK2 46/1 haplotype is a risk factor for myeloproliferative neoplasms in Chinese patients
    Zhang, Xinju
    Hu, Tingting
    Wu, Zhiyuan
    Kang, Zhihua
    Liu, Weiwei
    Guan, Ming
    INTERNATIONAL JOURNAL OF HEMATOLOGY, 2012, 96 (05) : 611 - 616
  • [29] The JAK2 46/1 haplotype predisposes to MPL-mutated myeloproliferative neoplasms
    Jones, Amy V.
    Campbell, Peter J.
    Beer, Philip A.
    Schnittger, Susanne
    Vannucchi, Alessandro M.
    Zoi, Katerina
    Percy, Melanie J.
    McMullin, Mary Frances
    Scott, Linda M.
    Tapper, William
    Silver, Richard T.
    Oscier, David
    Harrison, Claire N.
    Grallert, Harald
    Kisialiou, Aliaksei
    Strike, Paul
    Chase, Andrew J.
    Green, Anthony R.
    Cross, Nicholas C. P.
    BLOOD, 2010, 115 (22) : 4517 - 4523
  • [30] The JAK2 46/1 haplotype is a risk factor for myeloproliferative neoplasms in Chinese patients
    Xinju Zhang
    Tingting Hu
    Zhiyuan Wu
    Zhihua Kang
    Weiwei Liu
    Ming Guan
    International Journal of Hematology, 2012, 96 : 611 - 616
12345